To study the immune effect of p53 vaccines and impact of different antigenic regions, Bueter et al. designed 94 different peptides spanning the entire WT p53 protein and used these to stimulate PBMCs of colorectal cancer patients. The gene discussed is TP53; the disease is colorectal cancer.